- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MyMD Pharmaceuticals Inc (0A8D)
Assess today's live TNF Pharmaceuticals Inc (TNFA) share price, performance and insights using our live NASDAQ: TNFA stock exchange data.
Analyse the historical data and TNF Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on TNF Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the TNF Pharmaceuticals (TNFA) stock price today with other investors in the TNF Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TNFA share price (ISIN: US62856X2018) to enhance your trading decisions with our free investment tools and resources.
What Is the TNF Pharmaceuticals Inc Share Price Today?
The TNF Pharmaceuticals share price today is 0.35.
What Is the Stock Symbol for TNF Pharmaceuticals Inc
The stock symbol (or 'ticker') for TNF Pharmaceuticals Inc is "TNFA."
What Stock Exchange Does TNF Pharmaceuticals Inc Trade On?
TNF Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is TNF Pharmaceuticals Inc a Good Stock to Buy?
Determining whether TNF Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and TNF Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on TNF Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the TNF Pharmaceuticals (TNFA) stock price today with other investors in the TNF Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TNFA share price (ISIN: US62856X2018) to enhance your trading decisions with our free investment tools and resources.
What Is the TNF Pharmaceuticals Inc Share Price Today?
The TNF Pharmaceuticals share price today is 0.35.
What Is the Stock Symbol for TNF Pharmaceuticals Inc
The stock symbol (or 'ticker') for TNF Pharmaceuticals Inc is "TNFA."
What Stock Exchange Does TNF Pharmaceuticals Inc Trade On?
TNF Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is TNF Pharmaceuticals Inc a Good Stock to Buy?
Determining whether TNF Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
0.35
+0.35(+100,000.00%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.35
0.35
52 wk Range
0.35
3.48
0A8D Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.350.35
52 wk Range
0.353.48
TNF Pharmaceuticals Inc is currently considered to be UndervaluedExplore our list of undervalued stocks for hidden opportunities
TNF Pharmaceuticals Inc is not on our AI-picked strategiesExplore current and previous stocks selected by AI
Try Warren AI research assistant for instant insights on TNF Pharmaceuticals IncFrom metrics, to news, charts, and even a SWOT analysis - you can ask anything!
What you should know about TNF Pharmaceuticals IncHolds more cash than debt on its balance sheetHigh shareholder yield
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
0A8D Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
No news in this category
Looks like there are no results in this news category
TNF Pharmaceuticals Inc Company Profile
TNF Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to treat diseases and disorders marked by acute or chronic inflammation. The company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
Compare 0A8D to Peers and Sector
Metrics to compare | 0A8D | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0A8DPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −1.3x | −0.5x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | 0.1x | 1.0x | 2.6x | |
Price / LTM Sales | - | 0.8x | 3.0x | |
Upside (Analyst Target) | - | 407.9% | 54.1% | |
Fair Value Upside | Unlock | 17.8% | 9.4% | Unlock |
People Also Watch
FAQ
What Is the TNF Pharmaceuticals (0A8D) Stock Price Today?
The TNF Pharmaceuticals stock price today is 0.35
What Stock Exchange Does TNF Pharmaceuticals Trade On?
TNF Pharmaceuticals is listed and trades on the London stock exchange.
What Is the Stock Symbol for TNF Pharmaceuticals?
The stock symbol for TNF Pharmaceuticals is "0A8D."
What Is the TNF Pharmaceuticals Market Cap?
As of today, TNF Pharmaceuticals market cap is 978.05K.
What is TNF Pharmaceuticals Earnings Per Share?
The TNF Pharmaceuticals EPS is -13.34.
From a Technical Analysis Perspective, Is 0A8D a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.